The device had earlier FDA designation as a breakthrough device and received a new technology add-on payment from CMS, according to a May 31 news release. It is designed for sacropelvic anatomy.
The iFuse Bedrock Granite is also expected to reduce the need for reoperations in spinal deformity cases, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
